Used VITROS 5600 for Sale in Arizona
Phoenix and Scottsdale hospital labs run VITROS 5600 for integrated clinical chemistry, serving Arizona's growing hospital lab demand. Baseline pricing applies: $70,000–$140,000.
Arizona units run at national baseline: $70,000–$140,000.
VITROS 5600 - Key specifications
- Integrated analyzer
- clinical chemistry
Pricing in Arizona
VITROS 5600 vs alternatives
| Model | Brand | Used Price | Key Spec |
|---|---|---|---|
| VITROS 5600 ✓ | Ortho Clinical | $70,000–$140,000 | Integrated analyzer, clinical chemistry... |
| Optima L-90K | Beckman Coulter | $18,000–$32,000 | Ultracentrifuge, 90,000 rpm, 6 rotors... |
| Avanti J-26S XP | Beckman Coulter | $12,000–$22,000 | High-speed centrifuge, 26,000 rpm... |
| Sorvall LYNX 6000 | Thermo Fisher | $15,000–$28,000 | Superspeed centrifuge, 6000 rpm... |
Active buyers in Arizona
Facilities in Arizona currently using or sourcing VITROS 5600:
- Mayo Clinic Hospital, Phoenix
- Banner University Medical Center Phoenix, Phoenix
- Dignity Health St. Joseph's Hospital and Medical Center, Phoenix
- Valleywise Health Medical Center, Phoenix
- HonorHealth Scottsdale Osborn Medical Center, Scottsdale
Clinical experts on VITROS 5600
- Dr. Karen Carroll - Johns Hopkins Hospital, Baltimore. Roche cobas PCR validation and clinical microbiology.
- Dr. Robin Patel - Mayo Clinic, Rochester. 600+ publications on laboratory analyzers and diagnostics.
FAQ - VITROS 5600 in Arizona
Is VITROS 5600 well-suited to Arizona's hospital labs?
Yes - Arizona's growing hospital network benefits from VITROS 5600's simplified dry-slide chemistry operations.
What is the price of used VITROS 5600 in Arizona?
Arizona units run at national baseline: $70,000–$140,000. Price depends on hours, condition grade, and included accessories.
Does TechCosmetic ship VITROS 5600 to Arizona?
Yes. We ship to all 50 states including Arizona. Freight quotes within 24 hours, coordinated with local riggers in major Arizona cities.
More on VITROS 5600
Similar equipment
Zero buyer commission · 2-hour response